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Abstract
micro(mi)RNAs are small non-coding RNAs that negatively regulate expression of most mRNAs. They are powerful regulators
of various differentiation stages, and the expression of genes that either negatively or positively correlate with expressed
miRNAs is expected to hold information on the biological state of the cell and, hence, of the function of the expressed
miRNAs. We have compared the large amount of available gene array data on the steady state system of the NCI60 cell lines
to two different data sets containing information on the expression of 583 individual miRNAs. In addition, we have
generated custom data sets containing expression information of 54 miRNA families sharing the same seed match. We have
developed a novel strategy for correlating miRNAs with individual genes based on a summed Pearson Correlation
Coefficient (sPCC) that mimics an in silico titration experiment. By focusing on the genes that correlate with the expression
of miRNAs without necessarily being direct targets of miRNAs, we have clustered miRNAs into different functional groups.
This has resulted in the identification of three novel miRNAs that are linked to the epithelial-to-mesenchymal transition
(EMT) in addition to the known EMT regulators of the miR-200 miRNA family. In addition, an analysis of gene signatures
associated with EMT, c-MYC activity, and ribosomal protein gene expression allowed us to assign different activities to each
of the functional clusters of miRNAs. All correlation data are available via a web interface that allows investigators to identify
genes whose expression correlates with the expression of single miRNAs or entire miRNA families. miRConnect.org will aid
in identifying pathways regulated by miRNAs without requiring specific knowledge of miRNA targets.
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Introduction
Micro(mi)RNAs are small, 19–22 nucleotide long, non-coding
RNAs that regulate gene expression mostly by targeting the
39UTR of mRNAs resulting in reduced translation of proteins or
degradation of the mRNAs. miRNAs are fundamental regulators
of cell differentiation and developmental processes. They have also
been recognized to be highly relevant in cancer formation and
progression [1]. Recently it was demonstrated that almost all
human genes are under control of miRNAs [2]. However, because
miRNAs regulate the expression of hundreds of target genes [3],
and many genes are targeted by multiple miRNAs [4], assigning
biological functions to miRNAs or miRNA families has been a
difficult task.
miRNAs contain at their 59 end a short stretch of 6–8
nucleotides complementary to the seed match in the target
mRNA. This complementarity is accessible to computational
analysis and multiple algorithms have been developed to predict
miRNA targets [5]. However, target predictions made with these
algorithms are not accurate enough to deduce biological function
of miRNAs solely based on the lists of predicted targets. Target
validation is usually done by either overexpressing miRNAs or by
inhibiting their function followed by measuring the changes in
mRNA or protein levels in transfected cells [2,6]. However, both
overexpression and inhibition of miRNAs have caveats [7] and it is
not clear whether the observed changes at the mRNA and protein
level are the result of direct regulation by miRNAs or are the result
of changes downstream of the miRNA-targeted genes.
We have recently used the NCI60 cells [8], a panel of 60 cancer
cell lines maintained at the NCI, to identify and validate
connections between miRNAs and their targets. Unperturbed
array data points on expression levels of hundreds of miRNAs and
more than one hundred thousand gene probes on multiple array
platforms make the NCI60 cells a unique system to identify cancer
relevant connections between miRNAs and genes regulated by
miRNAs. Using the NCI60 system we previously validated
HMGA2 and IMP1 as targets of the let-7 family of miRNAs
[9,10]. In addition, we identified the members of the miR-200
family and validated two E-box binding transcription factors,
ZEB1 and ZEB2 as targets [11]. Most recently we validated the
tyrosine phosphatase FAP1 as a miR-200 target [12]. These
examples demonstrate the power of the NCI60 data sets to
connect miRNAs with their targets. However, identification of
single miRNA targets without a cellular context or knowledge of
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with biology or pathology. Our studies of let-7 and miR-200 in the
NCI60 cells also allowed prediction and confirmation of the
biological function of these miRNAs. Let-7 was found to be a
marker for differentiated cancer cells [9,13], and miR-200 was
identified as a powerful marker and regulator of the epithelial-to-
mesenchymal transition (EMT) [11,14].
Most of our findings were made by comparing miRNA and
mRNA expression levels, which at the time was surprising,
considering that miRNAs in mammalian cells were believed to
mostly act by translational silencing without affecting mRNA
expression levels. However, it had also been demonstrated that
mRNA abundance of the majority of the targeted genes was
somewhat affected by miRNAs [15,16]. While there is still
controversy on the predominant way by which miRNAs regulate
gene expression [17], a recent study suggested that, for a
substantial number of genes targeted by miRNAs, destabilization
of mRNA is the main mechanism of protein repression by
miRNAs [18], an observation that makes the NCI60 mRNA/
miRNA data sets a valuable tool for studying miRNA function in
cancer cells.
Transfecting cells with either miRNAs or miRNA inhibitors
usually results in changes in abundance of a large number of
mRNAs. Interestingly, mRNAs that are negatively regulated by
m i R N A sa r ef o u n d ,a sw e l la sal a r g en u m b e ro fm R N A st h a t
positively correlate with miRNA expression. These changes in
mRNA levels have generally been considered to be caused by
genes coregulated with miRNAs or to be secondary events.
Indeed, it is likely that the majority of genes whose expression
responds to changes in the expression of miRNAs are not direct
targets of the miRNA per se, but are biological effectors relevant
to the function of the miRNA. Especially when detected with
the steady state system of the NCI60 cells, these biological
effector genes may hold important information regarding the
endogenous function of miRNAs. This was most obvious for
miR-200.As m a l lc h a n g ei nmiR-200 expression (about 2 fold)
resulted in a moderate change in mRNA levels of its targets
ZEB1 and ZEB2 (about 5–7 fold), which resulted in a massive
change in the E-cadherin/Vimentin ratio (over 8 orders of
magnitude) [11]. The enormous positive correlation between
the expression of miR-200 and the E-cadherin/Vimentin ratio
allowed us to assign the function of ‘‘epithelial regulator’’ to the
miR-200 family even before we had identified ZEB1 and ZEB2
as targets. Encouraged by this analysis, we have now used the
NCI60 system to identify secondary correlators of miRNAs
(which can be in the thousands as in the case of EMT [19]) in a
genome-wide analysis as they can hold important information
on the biological state of a cell.
We have developed a novel method to cluster miRNAs or
miRNA families according to their biological correlators rather
than their predicted targets or their chromosomal colocalization or
their tissue specific expression. miRNAs were clustered into
distinct functional groups according to the expression of their
biological effector genes. We have validated the activity of one of
these clusters, which contains all members of the miR-200 family,
in regulating the epithelial nature of cells. This resulted in the
identification of three novel miRNAs, miR-7, miR-203 and miR-
375, to function in epithelial maintenance. In addition, we have
identified clusters of cancer relevant miRNAs that are either
growth promoting or growth suppressing in nature based on the
correlation of their expression with the expression of either
ribosomal proteins or c-MYC regulated genes. We have created a
web-based interface, miRConnect.org, which provides a robust
and easy-to-use tool for investigators to identify novel connections
between miRNAs or miRNA families and groups of genes that are
markers for various biological states.
Results
Generation of correlations between miRNA and gene
expression
In order to explore biological activities of miRNA we first
established the correlations between expression of miRNAs and
genes.Wemade useofseveral data sets availableforthe NCI60cells
(59 cell lines): 1) the expression profile of 208 human miRNAs
quantifiedbyreal-timePCR(the‘‘Q’’data set) [20];2)fourdatasets
of human gene expression profiles (STANFORD, GENELO-
GIC_U95, GENELOGIC_U133 and NOVARTIS) available on
theNCIDevelopmentalTherapeuticsProgram (DTP)server.Inthe
Q data set, 136 miRNAs were defined as being expressed at
detectable levels (as assessed by real-time PCR) in at least 30 of 59
cell lines (Table S1). The NCI60 cells represent 9 different cancers.
The cutoff of 30 cell lines was chosen to include at least half of cell
lines, and to ensure that at least four different tissue origins were
represented. An advantage of the NCI60 system is the ability of
combining individual endogenous miRNA expression in a way
represented by correlating gene expression with the expression of an
entire miRNA family (i.e., all 9 let-7 activities represented in the Q
data set). The 136 miRNAs contained members of 24 seed families
(miRNAs that share the same seed sequence with more than one
family member, Table S2). In addition, due to their predicted
overlapping function, we generated an additional custom family of
all miR-200 family members; miR-200 falls into two different seed
families, miR-141/200a and miR-200bc/429, distinguished by only
one nucleotide difference in the center of the seed sequence [11,14].
The most common and well-defined strategy to explore miRNA-
gene associations is the Pearson’s Correlation Coefficient (PCC)
[21,22]. While the PCC is a powerful tool to detect correlations, it
has limitations. For example, PCC gives equal weight to every
sample to be measured (e.g. a cell line, a specific tissue or a patient
sample). It does not differentiate between samples with high
expressionandoneswithlowexpression.Thismayleadtodistortion
of the correlation analysis, because: 1) the expression level of
miRNAs holds important regulatory information; and 2) noise is
more likely to exist in samples containing genes of low expression.
We therefore thought of a way to overcome some of these
limitations.Onesolutionwouldbetoassigndifferentweightstohigh
and low expression levels. However, because the PCC calculation is
not a linear process, it is not practical to add weights directly to each
sample. Instead, weighting at the level of the sample selection was
found to be more practical since PCCs of different arrays of cell line
data could be added up and the corresponding modeling would
again be linear. Based on this consideration, we developed a novel
method, the ‘‘summed PCC’’ (sPCC). A standard (direct) PCC
(dPCC), the sPCC and a randomizedsPCC (rsPCC) were appliedto
generate correlations between expression of miRNAs and genes, to
test the reproducibility of the correlations and explore the particular
biology of how miRNAs work.
Direct (d)PCC
In this method we performed a standard COMPARE analysis
[23], which produces PCCs, to identify mRNAs that correlated with
the expression of each of the 136 miRNAs. In this and all subsequent
COMPARE analyses we set 30 as the minimal number of detectable
cell lines. To normalize the detecting variation among probes
respectivelyincluded inthe four gene array platforms, the PCCs were
averaged for each gene. This method gave a PCC value for each
mRNA that significantly correlated with the expression of a miRNA.
Biological Function of miRNAs
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In this method (illustrated in Figure S1) we modified the
calculation process of miRNA-mRNA correlation by adding up a
series of PCC values mimicking a ‘‘titration’’ of miRNA by ranking
cell lines according to their expression of miRNAs. For each
miRNA-mRNA pair, we sorted miRNA expression in 59 cell lines
from highest to lowest, and selected the top 30 cell lines as the initial
condition, because these 30 cell lines represented the top half of all
thecell linesandincludedcellsfromat least4 different tissue origins.
We performed a COMPARE analysis for these 30 cell lines (pattern
30). Next, the cell line with rank No. 31 was included and a
COMPARE analysis was repeated for these 31 cell lines (pattern
31). Repeated COMPARE analyses were performed until all the 59
cell lines were included in an incremental way, and a total of 30
PCC values were generated (pattern 30 to pattern 59). We did not
use a sliding window of a fixed size (1 to 30, 2 to 31, …, 30 to 59)
because we always wanted to include the cell lines with the highest
expression of a miRNA expecting to have the greatest effect on
target/effector genes in these cell lines. This additive method
assigned weights in a gradient (or titration) way based on miRNA
expression levels. The 30 cell lines with the highest expression were
always included in each COMPARE calculation and assigned
highest weights, since we expected the greatest effects on target/
effector genes from these cell lines. The PCC sums were averaged
for each gene among the four gene array platforms.
Randomized summed (rs)PCC
In order to test the stability and reproducibility of the sPCC
method, we designed a randomized from of sPCC as an internal
control. The only difference between this method and the sPCC
method was that cell lines were sorted in a randomized way. For
each miRNA-mRNA pair, the randomized sorting was repeated
10 times and the 10 rsPCCs were averaged.
The sPCC method accurately detects both downstream
effector genes and predicted targets correlating with
miRNAs
It is known from multiple studies that although altering miRNA
expression levels in cancer cells causes both up and down
regulation of genes, miRNAs predominantly work through
negative regulation of downstream effector genes [15,16]. In
order to test this observation with our methods, the log2 ratio
values of all negative vs. all positive correlations were calculated
for 136 miRNAs respectively with the three methods (dPCC,
sPCC and rsPCC). A comparison of distribution of 136 ratio
values demonstrated that negative correlations significantly
outnumbered positive ones in the sPCC analysis but not in the
two other analyses (Figure 1A). The log2 ratio with the sPCC
method significantly shifted to the right compared to the dPCC
method. A higher number of miRNAs in the sPCC method had
negative correlating genes, which was canceled out by random
noise in the dPCC method (the median value was roughly zero).
The cumulative curve of rsPCC was similar to that of dPCC, but
was significantly different from that of sPCC. This demonstrates
that the sPCC method was more effective in detecting negative
correlations than either the dPCC or the rsPCC method.
Next we sought to compare the efficiency of the three methods
in detecting predicted targets. We chose TargetScan, a widely used
target prediction algorithm, to assemble a list of all human
miRNA-gene pairs involving the 136 miRNAs. The list was sorted
by total context score (defined by TargetScan for the conserved
targets) from highest to lowest (Table S3). Then incrementally
from top 50 to top 500 miRNA-gene pairs, the ratios of negative
vs. positive correlation numbers were calculated and plotted. Only
with the sPCC method, this ratio increased along with the increase
of total context score (Figure 1B). Therefore, results for all
correlations and the correlations with regard to predicted targets
both suggested that the sPCC method performed significantly
better at the theoretical level than either the dPCC or the rsPCC
method.
The sPCC method accurately detects expression of
miRNAs that are linked to single host genes as well as to
clusters of HOX genes
In addition to the theoretical level, it was necessary to test the
ability of the sPCC method to identify miRNA/gene connections
that have been established in known biological systems. We
therefore made use of both host genes and homeobox (HOX) genes
that have well characterized links to the expression of certain
miRNAs.
Many miRNAs are encoded within co-located genes (host genes)
and share promoters with them. Expression of these miRNAs
is driven by the promoters of their host genes, and positive
Figure 1. Performance of the NCI60 data sets to detect mRNA/miRNA correlations and to predict miRNA targets. (A) Cumulative plot
of log2 ratio of negatively vs. positively correlating gene numbers for 136 miRNAs calculated with the dPCC, sPCC and rsPCC methods, respectively.
The X-axis denotes the log2 ratio values of 136 miRNAs according to their ranking from lowest to highest, and the Y-axis denotes the cumulative
fraction of 136 miRNAs. The differences in the cumulative curves were measured by one-sided Kolmogorov-Smirnov Test. (B) Comparison of the three
methods to identify the most likely conserved TargetScan predicted targets in the human genome (a total of 33,535 predicted targeting events).
Target predictions were ranked by total context score from highest to lowest. Incrementally from top 50 to top 500 miRNA-gene pairs with the
highest total context scores, the ratio values of negative vs. positive correlation numbers were calculated and plotted for the three methods.
doi:10.1371/journal.pone.0026521.g001
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have been reported [22,24]. By utilizing this information, we
analyzed how often the co-transcription of miRNAs and their host
genes could lead to positive correlations in the NCI60 data sets. Of
the 136 miRNAs, 65 are encoded within host genes (Figure 2). In
both the sPCC and dPCC analyses the number of positive
correlations between host genes and their co-located miRNAs far
out-numbered the ones of negative correlations (Figure 2A and
2B). In contrast the analysis with the rsPCC method resulted in a
random distribution of positive and negative correlations (data not
shown). The results of the sPCC/dPCC methods were compara-
ble, suggesting that the reproducibility of NCI60 data sets was high
and the sPCC method to identify correlations was as good as the
dPCC method in the case of single host genes.
Next, we wanted to determine if the sPCC method would
perform better than the dPCC method in identifying specific co-
transcription. We took advantage of the HOX genes as a unique
system of four gene clusters, each containing at least one intergenic
miRNA. HOX genes regulate embryonic development and in
mammals they are grouped into 4 clusters (HOXA-D) including 9
to 11 genes [22,24]. Most of the HOX genes were positively
correlated with co-localized miRNAs (red boxes in Figure 3A).
Interestingly, the HOXA, HOXC, and HOXD clusters harbor one
miRNA gene each and the HOXB contains two (Figure 3A). We
first calculated dPCCs and sPCCs between the four miRNAs (miR-
10a, -10b, -196a, -196b), which are encoded within the HOX
clusters, and all human genes. We observed that in the sPCC
method, in 3 of 4 of the clusters a HOX gene adjacent to the co-
Figure 2. The endogenous miRNAs positively correlate with their host genes. (A) sPCC and (B) dPCCs values are given for the 73 miRNA/
host gene pairs represented in the Q data set and gene expression data sets which occurred with at least one of the methods. Reanalysis of the data
by comparing sPCC/30 with dPCC values with a cutoff of 0.2 revealed that the two methods do not differ in their ability to predict host genes (either
by paired t-test or paired Wilcoxon test).
doi:10.1371/journal.pone.0026521.g002
Biological Function of miRNAs
PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e26521localized miRNAs had the highest positive correlation with these
miRNAs out of ,18,000 human genes (miR-196b/HOXA9,
miR-196a/HOXC10 and miR-10b/HOXD8; bold red boxes in
Figure 3A). However, in the dPCC method, this was only true for
two clusters (miR-196b/HOXA10 and miR-196a/HOXC10) (data
not shown). For each of the 136 miRNAs, we calculated sPCC
values with genes in the 4 HOX gene clusters. The sPCCs of all
HOX genes within a cluster were added up and the miRNAs were
ranked according to the cumulative sPCC for each HOX cluster
(Figure S2). Remarkably, for each cluster there was one miRNA
that most clearly correlated with the expression of the HOX genes
in that cluster (red column in Figure S2), and in each case it was
the miRNA encoded within that cluster. To further compare the
performance of the sPCC and dPCC methods we plotted the
cumulative sPCC and dPCC scores for each HOX gene cluster
versus the correlating miRNAs (Figure 3B and 3C). The
cumulative sPCC and dPCC of the negatively correlating HOX
genes are also shown but were negligible. We also included miR-
99a/99b and miR-100 in this analysis because they share extensive
homology with miR-10a and miR-10b [25]. Once again, the sPCC
performed better than the dPCC method detecting the correct
HOX gene cluster for each correlating miRNA against a minimal
background signal from other clusters.
In summary, these data demonstrate that the steady state system
of the NCI60 mRNA and miRNA data is useful in detecting
biologically meaningful connections between miRNAs and their
host genes. The sPCC method, which was designed to mimic a
miRNA titration experiment, was superior to the dPCC method in
two assays (negative correlation with expressed mRNAs and HOX
gene cluster correlation) used for characterizing our approach.
The sPCC method was, therefore, used in the subsequent analyses.
miRConnect.org, a searchable web interface to explore
connections between miRNAs and their biological
effector genes
As introduced above, in addition to actual target genes, genes
that are not predicted to be miRNA targets as well as the large
number of both positively and negatively correlating genes may
hold important information with respect to the status of miRNA
cellular expression levels, which may provide insight into the
biological activities of miRNAs. All negatively and positively
correlating genes for the 136 miRNA and the 25 miRNA families
determined with both the dPCC and the sPCC method in the Q
data set, as well as the information on how many of them are
predicted targets by TargetScan 5.0, can be found under
miRConnect-Q at a searchable web interface: miRConnect.org
(or miRConnect.net)
Clustering of miRNAs based on overlap of their
correlating genes
Our data suggested that using the NCI60 data sets and the
sPCC method could be useful to detect biologically relevant
connections between miRNAs and their downstream effector
genes, which might provide new insights into biological activities
of miRNAs. We argued that genes either negatively or positively
correlated with a specific miRNA will be equally important
because each set may contain markers of a biological status
regulated in opposite directions. For example, E-cadherin and
Vimentin, which positively and negatively correlate with the
expression of the miR-200 family, respectively (CDH1 and VIM
in Table 1), both point at the EMT-related function of miR-200.
Therefore, we suggested that either negative or positive correla-
Figure 3. HOX genes positively correlate with the expression of the endogenous miRNAs that are encoded within these gene
clusters. (A) Structure of the four mammalian HOX gene clusters with the location of the hosted miRNAs. HOX genes boxed in red were detected as
positively correlated with the hosted miRNA using the sPCC method. For each cluster the HOX gene most strongly correlated with the miRNA that is
in that cluster is boxed in bold red. (B) sPCCs of all individual HOX genes in each cluster were cumulated and plotted against the members of the miR-
10/miR-196 family and miR-99a, -99b and -100.( C) Same as B but generated using the dPCC method.
doi:10.1371/journal.pone.0026521.g003
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miRNA or a group of miRNAs.
In order to test this assumption, we selected the top 2000
positive and top 2000 negative correlations and the corresponding
genes for each of 136 miRNAs, and performed a hierarchical
clustering to group the 136 miRNAs. We chose 2000 as a cutoff
because this number covered about 10% of all genes, which should
result in the elimination of most background noise. The clustering,
which is based on pair-wise comparisons represents the intersec-
tion of the genes that significantly correlate in their expression with
the expression of two different miRNAs (Figure 4 and Figure S3).
When positively correlating genes were assessed, a number of
miRNAs tightly clustered together (Figure 4). Similarly many of
the same miRNAs clustered together when negatively correlating
genes were used (Figure S3). Although numerous mechanisms may
be responsible for this clustering, we will refer to these as
‘‘functional clusters’’.
Interestingly, all 5 members of the miR-200 family were tightly
clustered, consistent with their similar biological activity (cluster I
in Figure 4 and cluster VI in Figure S3). In addition to miR-200,a
number of other structurally-related miRNAs formed functional
clusters according to the shared numbers of their effector genes.
Several seed families, such as miR-181abc, miR-19ab, miR-221/222,
miR-103/107 and miR-135ab, were clustered together tightly. In
contrast, members of several other seed families were found
scattered across different functional clusters (e.g. the let-7 or the
miR-30 family). This phenomenon suggested that the grouping of
miRNAs was partly based on, but not restricted to miRNA seed
sequences.
The clustering of miRNAs in this analysis was partially due to
the fact that some family members are part of the same
transcriptional unit. miRNAs that share chromosomal co-locali-
zation and also found in the same functional clusters included the
transcriptional units of miR-106b/93/25, miR-17,92, miR-194-2/
192, miR-183,182, miR-99b/let-7e/125a, miR-206/133b.
In some cases, miRNA clustering was based on neither the seed
match nor the genomic localization. For example, the members of
both the miR-141/200a and miR-200bc/429 seed families were
clustered together although they comprise two gene clusters on
separate chromosomes (cluster I, ‘‘Gene cluster’’ column in
Figure 4).
The NCI60 cell lines represent 9 different human cancers. To
determine whether the observed clustering of miRNAs was in part
due to tissue specific expression of either miRNAs or mRNAs, we
identified miRNAs that were preferentially expressed in any of the
9 human cancer types (Table S4; Table S5). Some correlations
with tissue of origin were found. For example, both clusters I
(including miR-200 family and miR-194) and XI (including the
miR-30 family) contained most of the miRNAs that are enriched in
colon cancer cells (Figure 4). Colon cancer cells may have a more
epithelial-like characteristic than most other cancer cell lines.
In summary, these data suggested that while common seed
sequences, chromosomal co-localization, and tissue specific
expression likely affected the co-expression of miRNAs with
certain genes and hence their grouping, many miRNAs were
clustered for other reasons. A major factor that determines
clustering could be the biological function of a miRNA, since the
clustering is based on the intersection of gene sets that positively
correlate significantly with two paired miRNAs. For example, miR-
200, -203, -375 and -7, which are grouped together in Figure 4
and Figure S3, do not have the same seed sequence, genomic
colocalization or specific expression in same tissue. The reason for
them to group together seems to be that they share similar
biological function in EMT regulation.
Identification of miRNA families involved in cell growth
regulation
c-MYC is not only a general regulator of miRNA function and
expression, but also itself regulated by miRNAs [26,27]. To
determine whether grouping miRNAs according to the identity of
correlating genes would detect the connection between miRNAs
and c-MYC, we used lists of genes that are either upregulated (460
genes) or downregulated (211 genes) by c-MYC (obtained from
http://www.myc-cancer-gene.org/) and determined how many of
them were either positively or negatively correlated with the
expression of each of the 136 miRNAs. The result is visualized in
Figure 5. The significance of enrichment of correlating genes was
determined by performing a Wilcoxon Rank-Sum Test. The
significance level is indicated by boxes with different colors.
Clearly, certain clusters of miRNAs were positively, and others
were negatively correlated with either c-MYC induced or c-MYC
repressed genes. Examples are the miRNAs in cluster V which
positively correlated with c-MYC induced genes and negatively
correlated with c-MYC repressed genes (Figure 5). In contrast
almost all miRNAs in clusters VIII, X and XIII showed the
opposite behavior.
c-MYC is known to be an important regulator of cancer cell
growth in part by regulating ribosomal biogenesis [28]. To
confirm the correlation found between clusters of miRNAs and the
growth of cells, we identified all ribosomal protein genes (RPs,
total number in the data set=99) with a sPCC of either .1o r
,21 in the data sets of correlating genes for each individual
miRNA. We would argue that a miRNA that is positively
correlated with a large number of RPs suggests a strong activity in
cell growth. In contrast miRNAs that are strongly negatively
correlated with RPs would indicate growth suppressive activity.
Table 1. sPCCs for a number of known EMT marker genes.
Mesen. Gene sPCC Epith. Gene sPCC
VIM 215.95 CLDN7 22.83
TWIST 215.13 CLDN4 19.77
SPARC 213.29 KRT8 17.96
ZEB1 213.05 JUP 17.94
CD44 28.20 CDH1 17.20
SMAD4 27.73 OCLN 15.53
FN1 26.22 KRT18 14.82
ZEB2 25.65 CTNND1 11.37
MMP2 24.67 KRT14 10.38
CDH2 24.63
MMP14 24.06
MMP16 23.91
TGFB1 23.34
FGF2 23.25
CDH11 22.51
SMAD2 22.51
SNAI2 22.33
FGFR1 21.89
TNC 21.45
COL3A1 21.23
Only sPCCs of .1a n d,21 are shown.
doi:10.1371/journal.pone.0026521.t001
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cluster of miRNAs that positively correlated with c-MYC induced
genes also positively correlated with the expression of RPs, and
every cluster that negatively correlated with the expression of c-
MYC induced genes also negatively correlated with the expression
of RPs (Figure 5). As the most significant examples, both c-MYC
induced genes and RPs positively correlated with the miRNAs in
cluster V, but negatively correlated in the miRNAs in cluster XIII
(Figure 5). We therefore concluded that clustering miRNAs
according to the expression of c-MYC regulated genes or RPs
allowed us to assign growth promoting and growth suppressing
activities to different miRNA functional clusters.
Identification of epithelial and mesenchymal specific
miRNAs
After we established the power of our analysis to functionally
link miRNAs with mRNAs, we sought to test the data in
identifying mRNAs that correlate with miR-200 and known EMT
markers. To identify EMT relevant genes that correlate with miR-
200, we determined the total activity of all 5 miR-200 family
members in the NCI60 cells. A number of well known EMT
marker genes and their sPCC are listed in Table 1. Canonical
mesenchymal genes such as Vimentin or Twist gave highly negative
sPCCs, and well-known epithelial marker genes such as E-cadherin
or cytokeratins 8 and 18 produced highly positive sPCCs.
Figure 4. Cluster analysis of 136 miRNAs based on a pairwise comparison of positively correlating genes using the sPCC method.
The miRNAs were divided into 13 functional clusters (I–XIII). Information is given for each miRNA on tissue specific expression, genomic co-
localization, and seed family. Stippled line: threshold of 12.5% of groups that was chosen to defined the 13 clusters.
doi:10.1371/journal.pone.0026521.g004
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together regardless of the approach used for clustering (cluster I in
Figure 4 and cluster VI in Figure S3), some other miRNAs were
co-clustered with the miR-200 family, such as miR-7, miR-203, miR-
375, miR-192 and miR-194. In order to determine whether these
miRNAs were positively correlated with the enrichment of
epithelial genes and negatively correlated with mesenchymal
genes, we analyzed three EMT-related gene signatures, each
representing a particular type of EMT process. EMT signature 1
was derived from primary human tubular epithelial cells
(HUTEC) before and after a 4-day treatment with TGF-b [29].
EMT signature 2 stemmed from Ha-Ras-transformed EpH4 cells
Figure 5. Correlation between selected gene signatures and the 13 miRNA functional clusters described in Figure 4. From left to right:
Signatures of c-Myc regulated (induced and repressed) genes, ribosomal proteins (RPs) and 3 groups of EMT-related genes. For the c-Myc and RP
signatures, each bar represents the number of genes that negatively correlate with a miRNA subtracted from the number of positively correlating
genes. Details on the gene signatures and the calculation of the E and M factors used to analyze the EMT signatures are described in the Method
section. Wilcoxon Rank-Sum Test was used to calculate significance for each functional cluster against the other clusters. Red, p,0.0001; orange,
p,0.001; yellow, p,0.01.
doi:10.1371/journal.pone.0026521.g005
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derived by comparing the differences in gene expression of
metaplastic carcinomas of breast (MCBs) and ductal carcinomas of
breast (DCBs) [31]. The three EMT gene signatures therefore
represented cases of a normal tissue, a transformed cancer model
and a primary human cancer, respectively.
In all three models, all 5 members of the miR-200 family
segregated in the cluster including the most epithelial miRNAs
together with miR-7, miR-203, and miR-375 (cluster I in Figure 5).
Figure S4A shows all miRNAs sorted from highest to lowest by
their E/M nature. For this analysis a universal EMT signature was
generated by taking the average of the EMT signatures 1–3. This
universal EMT signature was compared to miRNA regulated
genes determined using the sPCC method. Interestingly, miRNAs
identified as having the most mesenchymal nature, such as miR-
100, miR-125b and miR-99a, were also clustered together in all
three EMT signatures (cluster XIII in Figure 5). Figure S4B shows
the actual similarity of positively correlated genes among the
miRNAs with the highest and lowest E/M nature (colored
columns), generated by calculating overlapping percentages in
positively correlated genes between 16 miRNAs and the total
activity of the entire miR-200 family. The percentages among the
miR-200 family members ranged from 72% (for miR-141) to more
than 81% (for miR-200c). The miR-200 miRNAs were closely
followed by miR-203 (55%), miR-7 (48%) and miR-375 (45%). miR-
425* showed a much lower degree of identity in correlating genes
(22%). However, for the 7 most mesenchymal miRNAs, virtually
no genes were found to overlap with the genes that correlated with
expression of miR-200 (blue columns in Figure S4). These results
further validated the NCI60 data set as well as the sPCC method,
and identified novel, putative EMT-regulating miRNAs.
There were 10 miRNAs which were consistently grouped in an
‘‘epithelial’’ cluster, regardless of whether they were clustered
based on the positively or negatively correlated genes (Figure 6A).
Consistent with the analysis shown in Figure 5 and Figure S4, miR-
203, miR-7 and miR-375 were more closely related to miR-200
than miR-192 and miR-194. This was also confirmed by a
Principal Component Analysis for 136 miRNAs based also on
Figure 6. Validation of three predicted EMT-regulating miRNAs. (A) The EMT-related miRNA subcluster derived by using either positive
(upper) or negative (lower) sPCC values as described in Figures 4 and S3. (B and C) Ability of miRNAs in the epithelial cluster to cause upregulation of
E-cadherin in mesenchymal ACHN cells. ACHN cells were either transfected (B) once or (C) 3 times with the indicated miRNAs, and after (B) 3 days and
(C) 12 days respectively, the expression of E-cadherin mRNA was quantified by real-time PCR. The Western blot inserted in C confirmed that the
upregulation of E-cadherin mRNA also resulted in a induction of E-cadherin protein. (D) Comparison of the expression of the three new EMT-
regulating miRNAs between the epithelial (E) and mesenchymal (M) cell lines among the NCI60 cells recently described [11].
doi:10.1371/journal.pone.0026521.g006
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excluded from this analysis based on a previous analysis when only
the sPCC values were used to produce the cluster map rather than
the degree of overall in coexpressing genes (data not shown). In
addition, these two miRNAs also did not cocluster with the other
epithelial miRNAs in the Principal Component analysis (Figure S5).
All the cluster I miRNAs were found to co-cluster except for the two
miR-135 miRNAs. While miR-135a and miR-135b were above the
chosen cutoff in the analysis shown in Figure 4, they are the most
remotely related miRNAs to the core of the cluster I miRNAs. To
test whether the miRNAs in the epithelial cluster were merely
markers or were actively involved in the maintenance of epithelial
cells,wetransfectedeachofthe10miRNAsinthiscluster(Figure6A)
into the mesenchymal cell line ACHN, which does not express E-
cadherin [11]. Transfection of miR-7, miR-203,o rmiR-375 in addition
to the members of the miR-200 family caused upregulation of E-
cadherin mRNA within 3 days (Figure 6B). After three transfections
over 12 days, the level of E-cadherin mRNA induced by miR-203 was
even higherthan thatobserved with miR-200c (Figure 6C).However,
on the protein level, miR-203 was less effective than miR-200c,b u t
still significantly effective in upregulating E-cadherin (Figure 6C).
This analysis identified miR-7, miR-203,a n dmiR-375 as novel EMT
regulators in cancer cells and validated the core part of the cluster I
miRNAs (Figure 4) as regulators of EMT. Consistently, miR-7, miR-
203,a n dmiR-375, closely aligned with the miR-200 family, were
preferentially expressed in the epithelial cell lines that we have
recently described among the NCI60 cells (Figure 6D) [11]. This
suggests their epithelial role in vivo.
The identification of miR-7, miR-203, and miR-375 as markers for
epithelial cancer cells validated our hypothesis that the clustering of
miRNAs according to correlating gene overlap reveals new
functional similarities between miRNAs. We concluded, therefore,
that this analysis grouped miRNAs primarily according to their
function rather than their predicted targets, seed families or
genomic organization. Thus, miRConnect-Q can be used to
identify novel miRNA targets and downstream biological effectors.
Expanding miRConnect: miRConnect-L
miRConnect-Q is based on a set of expression levels of 208
miRNAs quantified by real-time PCR. Recently an additional set of
miRNA expression data became available based on LNA-
oligonucleotide arrays (the ‘‘L’’ data set) [32]. This new data set
contained information on 571 individual miRNAs for which the
oligonucleotides were uniquely selective. This number of miRNAs
allowed us to generate data on 53 miRNA seed families. We again
calculated the expression of the miR-200abc/141/429 custom
family. We generated correlation data sets using either the sPCC or
the dPCC method (with some modifications - see Method section).
Similar to the Q-data set we performed the analysis on the
correlation of miRNAs with their host genes (see Figure 2) and the
expression of the miR-10ab/196ab families with Hox genes (see
Figure 3) and again found a similar level of positive correlations
between the miRNAs and the host genes (data not shown). Similarly
both the analysisofEMTgenes(see Table 1)and thecluster analysis
(see Figure 4) gave confidence that the new L data were as useful as
the Q data (data not shown). Both data sets now cover a total of 583
individual miRNAs/376 miRNA seed sequences and 54 miRNA
seed families with more than one family member. All data can be
found as miRConnect-Q and miRConnect-L at miRConnect.org.
Discussion
While the ability to predict miRNA targets represented a great
advancement in the field and has helped to identify many miRNA
targets, the false positive rate of all of the algorithms is high. This
hampers accurate prediction of miRNA function based solely on
the list of predicted targets. While it is well established that the co-
expression of miRNAs which are part of the same transcriptional
unit is often indicative of a common biological function, it has not
been consistently so, and also has not permitted accurate grouping
of miRNAs according to their function. We now present a new
method to group miRNAs, which relies on identification of co-
expressed effector genes for which a large amount of functional
data is available.
Our analysis is based on three premises: 1) Cancer-relevant
miRNAs act in pathways that regulate cellular differentiation
stages which can be recognized by the signature of expression of a
number of stage-specific marker genes (i.e. E-cadherin for epithelial
cells or early carcinomas). 2) A substantial change in the expression
of these marker genes is brought about by a relatively small change
in the expression of genes that are actual miRNA targets (i.e.
ZEB1/2). MiRNAs therefore are part of amplification loops. 3) A
cancer-relevant differentiation stage is characterized as much by
expression of positively correlating marker genes (i.e. E-cadherin)a s
by negatively correlating ones (i.e. Vimentin) which are not direct
targets of the correlating miRNA (i.e. miR-200 does not target
Vimentin). Our method is complementary to existing methods and,
in conjunction with prediction algorithms and improved methods
for confirmation of actual in vivo targeting events [33], should allow
better prediction of the cancer relevant function of miRNAs.
A number of studies have addressed the question of miRNA
function using biocomputational approaches. These approaches
have all used target predicting information based on sequence
complementarities (e.g. TargetScan).
In one early work, a computational strategy to predict miRNA
regulatory modules (MRMs) was developed using bipartite graphs
to model miRNA-mRNA binding structures [34]. An extension of
the MRM concept was incorporated into a later computational
method to discover functional miRNA-mRNA regulatory modules
(FMRMs) [35]. This method associated expression data and
specific biological conditions (cancer versus normal tissue) with the
previous bipartite graph structure. An algorithm of population-
based probabilistic [36] and an alternative method of rule-based
learning [37] were also employed. However, these approaches all
relied on known target prediction algorithms and/or gene
ontology (GO) data, and were either theoretical, or did not
consider actual expression data, or were based on rules that were
generated using over-expression systems.
Two approaches [38,39] used Bayesian Network methods to
explore interactions between miRNAs and mRNA transcripts.
The first report developed a probabilistic graphical model for
miRNA regulation and variational learning for detecting miRNA
targets. The second report developed a strategy of splitting and
averaging of Bayesian networks (SA-BNs). In this method,
miRNA-mRNA interactions in the NCI60 cell lines were split
into different sample categories, and both up- and down-
regulation information was included. These improvements were
believed to capture stronger interactions than were detected using
conventional Bayesian Networks. However, this study only
described a subset of miRNAs and genes regulating EMT. The
analysis culminated in predictions on signaling networks regulated
by miRNAs using the Ingenuity pathway analysis software, which
is based on published data and requires constant updating. While
a Bayesian Network provides a powerful method for constructing
regulatory networks, it has its limitations in predicting miRNA
regulatory modules. 1) According to the definition of a Bayesian
Network, loop structure is not allowed, which means a Bayesian
Network cannot be applied to regulatory feedback loops as they
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between ZEB1 and the miR-200 family). 2) The learning procedure
of a Bayesian Network is computationally exhaustive [40], and the
space of possible structures is limited by gene number, as linear
increases in gene number cause exponential growth of the
required space.
A recent approach was based on the statistical enrichment of
miRNA targeting signatures in annotated gene sets. It allowed
prediction of a number of novel targets for various miRNAs and
prediction of disease relevant pathways [41]. However, this
analysis was again based solely on predicted functions of genes
and predicted seed matches, and actual expression data were not
considered. In addition, it used target prediction algorithms as well
as GO data. The analysis was based on a number of assumptions
and requires frequent updating, which may affect some of the
reported findings. In contrast to the previous approaches, our
study is based on actual and unperturbed gene expression data,
and none of our key findings rely on any known target prediction
algorithm or GO data.
The in silico titration method sPCC
Due to the nature of how miRNAs function, we designed the
sPCC method as an in silico titration. We argued that, in order to
detect mRNAs whose expression was repressed by miRNAs, the
miRNA had to be expressed. We predicted that very high
expression of miRNAs would suppress expression of targets
representing certain biological processes. In contrast, in cells
completely lacking expression of miRNAs, targeted genes would
either be expressed or not expressed as a consequence of other
regulatory mechanisms. In other words the ‘‘pressure’’ of a
miRNA on a gene should be best detectable by comparing cells
with high versus low expression of a miRNA. In order to reflect
this pressure, different weights were assigned to each of the cell
lines based on their miRNA expression levels. One could argue
that the classical PCC method might also be modified in this way.
However, in practical terms, it would be arbitrary to add weights
directly to each cell line. First, the PCC calculation is not a linear
process, and hence any change within the PCC function may have
uncontrollable consequences. Second, it would not be clear how
much weight to assign to each cell line. To solve this problem, we
adopted the ‘‘titration’’ method sPCC, with a gradient weighting
approach for cell lines sorted according to miRNA expression. We
decided to pick 30 cell lines as a threshold, for the following
reasons: 1) the model adds weight at the level of cell line selection,
so it is linear and additive for PCCs with different cell line
selections (e.g. from pattern 30 to pattern 59); 2) the model fully
considers the biological importance of the 30 cell lines with the
highest expression of each miRNA, as every pattern includes them;
and 3) the minimal number of 30 cell lines ensured the
methodological stability, as PCC is highly unstable and easy to
be interfered by background noise when its sample size is too small
(e.g. ,10). We intentionally reduced the importance of the rest of
the 29 cell lines, rather than simply neglecting them. If we had
performed the dPCC analysis by only using the 30 highest
expressing cell lines, it would be problematic since different sets of
cell lines would be selected for each miRNA. In order to test the
stability of our threshold selection, we used a randomized sPCC
(rsPCC) method as an internal negative control (Figure 1).
The performance advantage of the sPCC was obvious when the
methods were tested for the ability to detect the conserved miRNA
targets with the highest total TargetScan context score in the
human genome. Only with the sPCC method the correlation
increased with the more strongly predicted targets (Figure 1B). We
chose to use the TargetScan predicted genes as opposed to a list of
experimentally validated targets because TargetScan provides
total context scores, which can be used to rank predicted miRNA-
gene pairs (e.g. from top 50 to top 500). While most of these targets
are not validated it has been demonstrated that the number of
likely targets is greater towards the very top of each ranked list of
targets [15]. Our sPCC analysis confirmed this. Furthermore, the
sPCC method performed better in two other analyses (host gene
and HOX gene cluster gene correlations) when compared to the
dPCC method. Interestingly, only the sPCC was good enough to
group miRNAs for exploring their potential biological functions.
Regardless of whether positively or negatively correlating genes
were used, the dPCC method failed to group some of the most
biologically relevant miRNAs, such as members of the miR-200
and miR-17 families (data not shown). As an important control the
sPCC method performed far better than the randomized rsPCC
method. Hence, this method is robust enough to explore biological
functions of miRNAs. We decided to let the user decide whether to
use the dPCC or sPCC analysis on miRConnect.org. In summary,
our data demonstrate that across all NCI60 cells the sPCC method
performed best at both the theoretical and biological level,
permitting detection of general connections between miRNAs and
their downstream effectors.
Host genes and HOX genes
One mechanism that determines co-expression of miRNAs and
mRNAs is when both are driven by the same promoter. This is the
case for miRNAs that are part of host genes. A similar situation
occurs at the 4 human HOX gene clusters, which provided us with
a unique system in which each cluster of multiple genes contained
at least one miRNA gene. For both the host gene and the HOX
gene cluster case we found a highly significant correlation between
the expression of the gene(s) and the miRNAs that are linked to
their co-transcription. Of the 73 host gene/miRNA pairs in our
analysis of the Q data set, 37 showed a positive sPCC, but negative
sPCCs were only found in 5 cases and they were of low
significance (Figure 2A). The correlation of miRNAs with their
hosting HOX genes was even more impressive. In each case a
substantial number of HOX genes positively correlated with the
expression of the miRNA in that cluster (9/11 HOXA genes with
miR-196b, 8/10 HOXB genes with miR-10a, 5/9 HOXC genes with
miR-196a, and 6/9 HOXD genes with miR-10b), and few HOX
genes negatively correlated with these miRNAs. This analysis in
particular illustrates the strength of the expression correlation that
can be found using the NCI60 data analysis. The sPCC method
achieved the highest positive correlations between the four
miRNAs and their adjacent HOX genes. Out of ,18,000 human
genes the following HOX genes had the highest positive sPCC for
the miRNAs that are coded within a HOX gene cluster: HOXA9
and miR-196b, HOXB7 and miR-10a, HOXC10 and miR-196a and
HOXD8 and miR-10b. Interestingly, our data allow us to predict
that miR-196a-1, which is part of the HOXB gene cluster, is not
significantly expressed in cancer cells, since neither of the two
methods of analysis detected any HOXB genes that were co-
expressed with this miRNA (Figure 3B and 3C).
Novel and unusual predictions that come out of our
analysis
Our analysis makes a number of predictions that cannot be
explained based on current knowledge. These include the
prediction that let-7 is a family of at least 6 different potential
activities in cancer cells (functional clusters II, IV, V, VI, X and
XIII in Figure 4). Our data now provide the impetus to look into
this phenomenon. We hypothesize that nine different let-7 family
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let-7.
The finding that seems to be most at odds with published data is
our results on miR-21. miR-21 is the miRNA upregulated in the
most human cancers when compared to normal tissue [42], and
miR-21 was recently shown to induce neoplastic transformation
when expressed as a transgene in mice [43]. Confirming published
data, miR-21 expression negatively correlated with two of its main
validated targets, PDCD4 [44,45] (sPCC=24.7) and PTEN [46]
(sPCC=21.05). miR-21 has, therefore, been viewed as an
oncogenic miRNA, and one would expect it to be one of the
most growth-promoting miRNAs. It was surprising, therefore, that
in our study miR-21 was co-clustered with miRNAs that had a
strong negative correlation with genes induced by c-MYC
(functional cluster X in Figure 5), which would indicate a growth
suppressing activity. We also determined the extent of correlation
between the expression of miRNAs and 99 ribosomal genes as
markers for cell growth. Interestingly and consistently with the
results on the c-MYC regulated genes, expression of miR-21 had a
strong negative correlation with the expression of almost all
ribosomal genes. In fact when the miRNAs were ranked according
to the correlation with ribosomal genes, miR-21 was the third most
clearly negatively correlating miRNA (Figure S6). How could this
finding be reconciled with the existing paradigm of miR-21 being
such a significant marker for cancer cells? We recognize that all
reports identifying miR-21 as being overexpressed in cancer cells
were based on comparisons of cancer with normal cells [42], while
our analysis does not include normal cells. Our finding may,
therefore, have revealed a cellular function of miR-21 that is not
cancer specific. Interestingly, there is very little information on the
physiological function of miR-21 outside of cancer. However, two
pieces of data provide a clue as to the physiological activity of miR-
21. In the context of a cancer cell line, in an unbiased approach 94
different endogenous miRNAs were individually inhibited in HeLa
cells. Inhibition of most miRNAs resulted in reduced growth of the
cells. Only two miRNAs were identified as growth repressors, as
their inhibition accelerated the growth of the cells. By far the most
growth suppressing miRNA was miR-21 [47]. In normal tissues
miR-21 has also been recognized as a paradoxical miRNA [48]. In
the context of heart hypertrophy, miR-21 was reported to inhibit
hypertrophy of cardiomyocytes [49]. Based on these data and our
analysis we predict that one of the physiological activities of miR-
21 is to inhibit, rather than to promote, cell growth.
EMT markers and new EMT regulators
Induction of EMT induces changes in expression of thousands
of genes in the human genome. Many of these changes involve
sharp on-off regulation of genes. Examples of genes that are
regulated in a switch-like manner are E-cadherin and Vimentin where
the difference in the ratio of their expression across the NCI60
cells spans 8 orders of magnitude [11]. Neither E-cadherin nor
Vimentin are direct targets of miRNAs that regulate EMT, but they
are powerful markers for the two cellular stages of epithelial and
mesenchymal cells. Interestingly, the remarkable similarity in the
genetic programs of EMT is documented by the three EMT gene
signatures used in this study, and the resulting similarity in
correlation of gene expression with that of certain groups of
miRNAs. Our analysis allowed us to identify and validate three
new regulators of epithelial cells, miR-7, miR-203 and miR-375.
miR-7 was previously shown to target the epidermal growth factor
receptor (EGFR), a known regulator of EMT [50], and EGFR was
also the gene with the highest TargetScan total context score that
was most negatively correlated with miR-7 expression
(sPCC=22.26; see miRConnect.org). miR-203 was recently
linked to EMT regulation and stem cells [51]. In our analysis,
miR-203 was a potent inducer of E-cadherin upregulation. Predicted
targets include the EMT regulator Snail2 (Slug) which also had a
low negative sPCC of 28.01 (miRConnect.org). Finally miR-375
was recently reported to target 3-phosphoinositide-dependent
protein kinase-1 (PDK1) [52] which promotes invasion and
activation of matrix metalloproteinases [53]. We also identified a
number of miRNAs that are co-expressed with mesenchymal
genes. Among these we found miR-155, which we had already
identified as most highly expressed in mesenchymal cancer cells
[11], and this was recently confirmed by others [39].
miRConnect-Q and miRConnect-L
On the miRConnect.org site we have made data sets available
based on two different miRNA expression data sets. In a recent
analysis the level of concordance between 4 different miRNA
expression data sets obtained with the NCI60 cells was moderate
[32]. The PCC between the L and the Q data sets used in our
study was found to be 0.56. Nevertheless we found that the
discrepancies were often in miRNA species with relatively low
expression levels. Data on major miRNA families including let-7,
miR-200 or the miR-17,93 family were more consistent (data not
shown). Regardless of the nature of the differences they must not
necessarily be due to fluctuation between the analyses. The two
platforms that generated the Q and the L data sets are very
different and each has both advantages and caveats. The LNA-
based arrays that underlie the L data set cannot discriminate
between mature miRNAs and their pre-miRs but are more robust
in detecting different isomiRs. In contrast, the Q data set relies on
real-time PCR involving loop primers. While they are highly
selective for the mature miRNAs they cannot distinguish between
certain isomiRs. This could be relevant because in a recent study it
was demonstrated that miRNAs exit as multiple isomiRs and this
varies among species and tissues [54]. We therefore decided to
make the analysis based on both data sets available on
miRConnect.org.
Expression levels of miRNAs and mRNAs have been correlated
previously in attempts to establish causality [22,55,56,57,58]. This
has been complicated by the fact that certain mRNAs are both
regulators of miRNA expression/biogenesis and targets of these
miRNAs. Examples are c-MYC and let-7, and ZEB1/ZEB2 and
miR-200 [59,60]. Our work provides an additional way to link
miRNA expression to biological function (i.e. miR-200 to EMT or
miR-10/miR-196 to HOX gene expression) without the need to
validate specific mRNAs as miRNA targets.
Based on our data, we propose to focus more on individual
pathways when assigning cancer relevant functions to miRNAs
and less on global activities. We believe that the functional
grouping of miRNAs using miRConnect will significantly aid
miRNA researchers and will provide a novel resource to the field
that complements the study of miRNA function based on their
seed sequences. We propose to group miRNAs families according
to seed families, gene clusters, and functional correlations.
Methods
The miRNA data sets
The Q data set. The real time PCR data (ct values) for 207
individual miRNAs was previously described [20], and expression
data for each miRNA can be found at http://dtp.nci.nih.gov/
mtargets/download.html as WEB_DATA_ISRAEL_MIR.ZIP.
For each miRNA the number of cell lines with an expression
level above the limit of detection was determined. The real time
PCR data set for miR-429, which was not part of the original data
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Lebanon, NH). Expression of the miRNA was determined by
normalizing the data set as previously described [11]. Each
miRNA was assigned to a miRNA seed family (miR_family) as
defined by TargetScan.org. To develop the sPCC method, the
integration of miRNA IDs and measurements was done using a
customized Java platform (Netbeans java console project
MicroRNAparser). A few miRNAs were not explicitly included
in the TargetScan family assignments and a few used different
nomenclatures than that used in TargetScan. In these instances
miR_family assignments were made based on sequence (see Table
S5). For any miR_family that contained two or more miRNAs
detectable in at least 30 cell lines, an average expression of 59 cell
lines (family_average) was calculated for the mir_family. The
miRNA and miR_family data were used to generate linked subsets
of cell line data. Each member of these subsets was used as a seed
for COMPARE analysis, and the sets of COMPARE results,
linked by miRNA or miR_family, were aggregated.
The L data set. The LNA array based expression data (log2
ratios) of 955 individual miRNAs were recently described [32] and
can be found at GEO (accession number: GSE26375). Of these
955 miRNA probes 571 were specific for only one miRNA (with
no crossreactivity with other miRNAs) and were therefore used in
our study. Total expression of an entire seed family was
determined by adding the individual expression values of all
members. To have more control of the analysis locally we chose to
analyze the L data set by using R software.
The mRNA data sets
The analyses performed in this work covered a total of 130,368
individual gene array probes in the MICROARRAY_ALL target
set available at the DTP site (http://dtp.nci.nih.gov/mtweb/
search.jsp). Of these, 82,564 gene probes had GeneCard identifiers
(distributed over 4 array platforms: STANFORD: 7328 genes,
GENELOGIC_U95: 34,309 genes, GENELOGIC_U133: 31,266
genes, and NOVARTIS: 9661 genes) and they represented 18,462
uniquely known genes in the human genome.
COMPARE analysis
COMPARE analysis was used to generate correlations between
the data in the miRNA Q data set and the gene array data.
COMPARE is a computational tool available through the NCI
DTP web site. (http://dtp.nci.nih.gov/compare). It was developed
in the early 1990’s to explore the results from the NCI60-cell line
screen [23] but has since been adapted as a web based tool
[61,62]. The COMPARE algorithm ranks the members of the
data set based on the similarity of the responses or expression
levels of a single set of cell line measurements. The similarity
metric used is a Pearson Correlation Coefficient (PCC).
The dPCC method
To generate miRConnect-Q, each of the 136 miRNAs with at
least 30 cell lines with detectable expression and each miRNA of
the 25 families was used as a seed for a single COMPARE analysis
against 18,747 genes. The microarray features for all COMPARE
correlations were collected. Correlations for microarray features
associated with named genes (GeneCard/Human Genome
Organisation/HUGO, www.HUGO-international.org) were then
determined by averaging the individual correlations for each gene.
To generate miRConnect-L, the expression profiles of 571
miRNAs/53 miRNA families and 18,747 genes in 59 cell lines
were used to calculate a Pearson Correlation Coefficient (PCC)
between each miRNA and each gene. Then, the average values of
PCCs between each miRNA and each gene were calculated across
all 4 gene array data sets for gene expression to normalize for
variation among different microarray platforms. These averaged
values were designated direct PCC (dPCC). During this process
missing values were excluded. The top 2000 positive and negative
dPCCs (covering about 10% of all genes) were collected to
perform the EMT, c-MYC, and RPs correlations. This resulted in
the elimination of 97% of the correlations with dPCCs
corresponding to values between 20.3 and +0.3.
The sPCC method
To generate miRConnect-Q, detectable miRNAs and miRNA
families were used to generate linked subsets of cell line expression
data, referred to as ‘‘patterns’’. Before creating the patterns, the
cell lines were ranked by their miRNA expression from highest to
lowest (or decreasing average expression in the case of miRNA
families). For each miRNA or miRNA family, pattern 30 consisted
of the first 30 cell lines (those with the highest levels of expression),
pattern 31 included all of the cell lines from pattern30 and the cell
line with the next highest level of expression, pattern 32 included
all of the cell lines from pattern 31 and the cell line with the next
highest level of expression, and so on. The last pattern, pattern 59,
consisted of all of the cell lines and completed the set of linked
patterns each with 30 members. Each individual pattern was used
as a seed for a single COMPARE analysis against the MICRO-
ARRAY_ALL target set. After COMPARE had been run on all
30 linked patterns, the sum of the COMPARE correlations
(sum_correlation) for each microarray feature for the 30 patterns
was determined. Correlations for microarray features associated
with named genes (GeneCard/HUGO) were then determined by
averaging the individual correlations for each gene. The top 2000
positive and negative sPCCs (covering about 10% of all genes)
were collected to perform the EMT, c-MYC, and RPs calculations.
For miRConnect-L, R software was used to generate sPCC values.
Subsequently the sum of PCCs for these 30 patterns was added up
to calculate each sPCC value. Variations within sPCCs across
different gene array platforms were eliminated by taking average
values across different platforms.
The rsPCC method
The only difference between the rsPCC method and the sPCC
method was that rsPCC generated patterns according to
randomized sorting of cell lines. Each rsPCC was repeated 10
times, and average of the calculations was taken.
Processing TargetScan
Predictions and underlying data for TargetScan version 5 were
downloaded at http://www.targetscan.org. The TargetScan data
sets were used to generate predictions for microRNA families, to
limit those predictions to conserved miRNA, and to generate
custom predictions for families that we defined. These manipu-
lations were based on the descriptions of the TargetScan
algorithms which were included on the TargetScan 4.2 web site,
with slight modifications to accommodate changes in the
downloadable data as follows: Predictions were limited to those
predictions that included at least one human example, context_
scores .0 were not included in the determination of total_con-
text_score, and the aggregate prediction for a miRNA family was
the minimum total_context_score for any miRNA that was a
member of that family.
Generation of the searchable web interface miRConnect
A table of miRNA/mRNA pairs was loaded into a (MySQL)
database along with their correlation values, mRNA chromosome
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A web interface was built to filter and extract data from this table.
Genes can be shown that correlate positively or negatively with a
given miRNA or miRNA family, according to the dPCC or the
sPCC method. If no miRNA is selected but instead a list of mRNA
gene IDs are entered, then miRNAs that correlate will be listed. For
negative correlations, TargetScan total_context_score was also
provided. Functional annotation search words can be used to
constrain the output, and all output tables are downloadable in
spreadsheet-ready form. The site contains all data on miRConnect-
Q and -L and is accessible at miRConnect.org.
Host gene and HOX gene analyses
The miRNA host genes were retrieved by comparing the genomic
positions of miRNAs and genes as recently described [63]. All the
analyses were based on the genomic coordinates of human assembly
build36.1.ForbothmiRNA/geneassociationmethods,weobtained
dPCC/sPCC statistics between host genes or HOX family genes and
the miRNAs. In order to spotlight the miRNAs associated with HOX
gene clusters, for each miRNA we summed up the dPCC/sPCC for
all the members in each HOX gene clusters.
Identification of cancer specific miRNAs
Specifically expressed miRNAs in each type of cancer were
screened out by Significance Analysis of Microarrays (SAM) with a
manually adjusted False Discovery Rate (FDR). FDR was set as
0.01 (Table S4).
Hierarchical clustering of miRNAs and Principal
Component Analysis based on identity of correlating
genes
For the sPCC positively and negatively associated gene lists, we
queried all possible pairs of miRNAs with either the top 2000 sPCC
values (for positive correlations) or bottom 2000 sPCC values (for
negative ones) and calculated the percent identity of overlapping
correlated genes between any two miRNAs. Thus 1366136
matrices for the overlapping gene numbers were generated. Then
both matrices were transformed to distance matrices by using
Euclidean distance measure (R function: as.dist). Complete linkage
method was used to find similar clusters (R function: hclust) for
dendrogram plotting. Functional clusters of miRNAs were defined
by miRNAs that shared more than 12.5% correlating genes (R
function: cutree). Principal component analysis (PCA) was adopted
to do a orthogonal transformation, converting correlated miRNAs
into an equal size of uncorrelated variables called Principle
Components (PCs). The 1366136 matrix for the positively
overlapping gene numbers was used to do orthogonal transforma-
tion using the R function prcomp. The two principal components
with the highest score were used to generate a PCA plot.
The gene expression signatures
Two sets of gene signatures were used. 1) c-MYC regulated genes.
A non-redundant list of 460 genes upregulated by c-MYC and 211
genes suppressed by c-MYC was obtained from the c-MYC target
gene database (http://www.myccancergene.org/) [64]. 2) Genes
regulated during EMT. Three EMT gene signatures from previous
studies were used in the analysis. There are 86, 72, and 121
epithelial genes and 59, 79, and 87 mesenchymal genes in the
studies of Campanaro et al. (EMT 1), Jechlinger et al. (EMT 2), and
Lien et al. (EMT 3) [29,30,31], respectively. We determined
whether the expression of every gene in these lists negatively or
positively correlated with the expression of the 136 miRNAs. The
number of genes whose expression negatively correlated with a
given miRNA was subtracted from the number of genes that
positively correlated and plotted across all 136 miRNAs in the
cluster analysis using either the dPCC or the sPCC method.
Statisticallysignificantpositivecorrelationsbetweengene expression
and the expression of miRNAs in each of the 13 clusters detected
with the sPCC method were determined using the Wilcoxon Rank-
Sum Test. A p value of 0.01 was considered significant. For the
EMT analysis an epithelial/mesenchymal (E/M) factor was
determined as follows: (negatively correlating M genes - positively
correlating M genes)+(positively correlating E genes - negatively
correlating E genes)=E/M factor. The E/M factor was used to
rank miRNAs according to their E/M nature in Figure S4.
Testing epithelial specific miRNAs for their ability to
upregulate E-cadherin in mesenchymal cells
Mesenchymal ACHN cells which express little E-cadherin were
serially transfected with pre-miRNAs (Ambion) up to 3 times as
described [11]. Western blot analysis and real time PCR for E-
cadherin were performed as described [11].
Statistical analyses
R statistical program v2.10 (http://www.r-project. /) was
used to perform microarray data manipulation, dPCC calcula-
tions, sPCC/dPCC/rsPCC comparisons, miRNA target enrich-
ment, hierarchical clustering, host gene and HOX gene analyses,
PCA analysis, and gene expression signature calculations.
Supporting Information
Figure S1 Schematic to illustrate the sPCC method.
(PDF)
Figure S2 For each of the HOX gene clusters the
expression of the hosted miRNA best correlates with
the expression of the HOX genes in that cluster. The
sPCC values for the genes in each HOX gene cluster were
cumulated for the 136 miRNAs and plotted by ranking 136
cumulative sPCC values from highest to lowest. For each HOX
cluster the top ten miRNAs are listed in a table.
(PDF)
Figure S3 Cluster analysis of 136 miRNAs based on a
pairwise comparison of negatively correlating genes
using the sPCC method. The miRNAs were divided into 17
functional clusters (I–XVII). Stippled red line: threshold of 12.5%
of groups that defined the 17 clusters.
(PDF)
Figure S4 miRNAs that are most epithelial and most
mesenchymal in nature according to their positively
correlated genes. (A) Ranking of 136 miRNAs according to
their correlation with the expression of either E or M genes
calculated by taking sPCCs related to the average of EMT
signatures 1–3 (see Figure 5). All 5 miR-200 family members
(shown in red) were found in the top 9 miRNAs most positively
correlated with the expression of E genes (left stippled line).
Additional E related miRNAs, miR-203, miR-7, miR-375 and miR-
425* are shown in orange. The miRNAs best correlating with the
expression of M genes are labeled in blue (defined by stippled line
on the right). (B) Overlap in positively correlated genes between
the entire miR-200 family and the miRNAs that are most epithelial
in nature (red/orange) or most mesenchymal in nature (blue).
(PDF)
Figure S5 Principal Component Analysis of 136 miRNAs
according to positively correlating genes, with the two
Biological Function of miRNAs
PLoS ONE | www.plosone.org 14 October 2011 | Volume 6 | Issue 10 | e26521
orgPCs (PC1 and PC2) with the highest score plotted. The
epithelial subcluster of miRNAs that regulated E-cadherin (see
Figure 6) is labeled by a red circle.
(PDF)
Figure S6 Correlation of miRNA expression with that of
ribosomal protein genes. The 136 miRNAs that correlated in
their expression with those of ribosomal genes (RPs) were ranked
according to the number of RPs that had positive or negative
sPCC values with individual miRNAs. Rank order was determined
by the factor: [number of positively correlating RPs] - [number of
negatively correlating RPs].
(PDF)
Table S1 Expression of miRNAs in 59 of NCI60 cell lines
sorted according to numbers of cell lines with detectable
expression. miR-429 was found to be significantly expressed in
more than 30 cell lines (data not shown).
(XLS)
Table S2 miRNA seed families represented in the Q
data set. miRNAs in red=family members for which no
data sets were available.
(XLS)
Table S3 Analysis of the top 500 conserved genes
predicted by TargetScan in the human genome to be
targeted by one of the 136 miRNAs.
(XLS)
Table S4 Identification of miRNAs with tissue specific
expression. FDR: False Discovery Rate.
(XLS)
Table S5 miRNAs that are part of either seed families,
gene clusters or are tissue specifically expressed.
(XLS)
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